KIT and acute myeloid leukemia: To investigate the efficacy and safety of avapritinib in the treatment of molecular biologically positive core binding factor-acute myeloid leukemia(CBF-AML)with KIT mutation after allogeneic hematopoietic stem cell transplantation(allo-HSCT).